Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
|
|
Cerevel Therapeutics Holdings, Inc. (CERE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/02/2020 |
8-K
| Director compensation was amended/approved|
Docs:
|
"Amended and Restated Registration and Shareholder Rights Agreement, by and among Cerevel Therapeutics Holdings, Inc. and the stockholders party thereto",
"Lease Agreement, by and between Cerevel Therapeutics, LLC and FHF I 131 Dartmouth, LLC",
"Lease Agreement, by and between Cerevel Therapeutics, LLC and DW Propco JK, LLC, as amended on September 1, 2020",
"Forms of Award Agreements under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan",
"Form of Subscription Agreement (incorporated by reference to Annex F to the Proxy Statement/Prospectus)",
"Form of Subscription Agreement (incorporated by reference to Annex F to the Proxy Statement/Prospectus)",
"Employment Agreement, by and between Cerevel Therapeutics, LLC and John Renger",
"Senior Executive Cash Incentive Bonus Plan",
"Severance Benefits Policy for Specified C-Suite Executives",
"Non-Employee Director Compensation Policy" |
|
|
|